POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

S. Mouallif,K. Thomas,N. E. Adlard,P. Cooney,F. Blanchette,B. P. Patel,M. Baharnoori,V Bhan,F. Clift,D. Grima

Value in health（2022）

引用 0|浏览45

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要